Home ETF List About

Portfolio Holdings Detail for ISIN IE00B8FHGS14
Stock Name / FundiShares Edge MSCI World Minimum Volatility UCITS ETF USD (Acc)
IssuerBlackrock
Entity holding fund iShares VI Public Limited Company
Entity TypeUmbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300VML6THE3JJOS76
ETF TickerMINV(GBX) LSE
ETF TickerIQQ0(EUR) F
ETF TickerMINV.LS(GBX) CXE
ETF TickerMVOL.LS(USD) CXE
ETF TickerMVOL.MI(EUR) CXE
ETF TickerMVOLz(CHF) CXE
ETF TickerMVOL(EUR) ETF Plus
ETF TickerMINV.L(GBP) LSE

Holdings detail for NBIX

Stock NameNeurocrine Biosciences Inc
TickerNBIX(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS64125C1099
LEI549300FECER0XBN49756

Show aggregate NBIX holdings

News associated with NBIX

Sum Up The Parts: SCHG Could Be Worth $34
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-08-21 10:23:31
Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Shares Sold by Maryland State Retirement & Pension System
Maryland State Retirement & Pension System lowered its position in shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) by 12.5% during the 1st quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 4,661 shares of the company’s stock after selling 663 shares during the quarter. Maryland […] - 2025-08-15 05:24:56
Charles Schwab Investment Management Inc. Purchases 13,216 Shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX)
Charles Schwab Investment Management Inc. raised its position in shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) by 1.7% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 775,773 shares of the company’s stock after acquiring an additional 13,216 shares during the quarter. Charles […] - 2025-08-13 05:10:46
Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Shares Sold by Blair William & Co. IL
Blair William & Co. IL cut its stake in Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) by 3.7% in the first quarter, Holdings Channel reports. The fund owned 6,214 shares of the company’s stock after selling 242 shares during the period. Blair William & Co. IL’s holdings in Neurocrine Biosciences were worth $687,000 at the […] - 2025-08-11 05:52:52
Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Shares Sold by Federated Hermes Inc.
Federated Hermes Inc. trimmed its holdings in shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) by 72.9% during the first quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 9,441 shares of the company’s stock after selling 25,402 shares during the quarter. Federated Hermes Inc.’s […] - 2025-08-07 05:22:58
Natixis Advisors LLC Sells 292 Shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX)
Natixis Advisors LLC lowered its position in Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) by 0.9% in the first quarter, Holdings Channel.com reports. The institutional investor owned 33,312 shares of the company’s stock after selling 292 shares during the period. Natixis Advisors LLC’s holdings in Neurocrine Biosciences were worth $3,684,000 at the end of the […] - 2025-08-07 04:49:07
Neurocrine (NBIX) Q2 2025 Earnings Call Transcript
@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo - 2025-08-05 01:16:10
Neurocrine (NBIX) Q2 Revenue Jumps 17%
Key PointsNon-GAAP earnings per share of $1.65 for Q2 2025 vastly exceeded the analyst estimate of $0.96. - 2025-08-01 01:15:16
13,202 Shares in Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Bought by Y Intercept Hong Kong Ltd
Y Intercept Hong Kong Ltd acquired a new position in shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) in the 1st quarter, HoldingsChannel.com reports. The fund acquired 13,202 shares of the company’s stock, valued at approximately $1,460,000. Other hedge funds and other institutional investors have also recently bought and sold shares of the company. […] - 2025-07-24 06:50:57
HighPoint Advisor Group LLC Purchases 366 Shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX)
HighPoint Advisor Group LLC boosted its position in shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) by 15.0% during the first quarter, Holdings Channel.com reports. The fund owned 2,812 shares of the company’s stock after acquiring an additional 366 shares during the quarter. HighPoint Advisor Group LLC’s holdings in Neurocrine Biosciences were worth $302,000 […] - 2025-07-24 05:51:14
Neurocrine Biosciences (NASDAQ:NBIX) Now Covered by Analysts at Truist Financial
Truist Financial initiated coverage on shares of Neurocrine Biosciences (NASDAQ:NBIX – Free Report) in a research report report published on Monday, Marketbeat reports. The firm issued a buy rating and a $163.00 price target on the stock. NBIX has been the subject of several other reports. Royal Bank Of Canada reaffirmed an “outperform” rating and […] - 2025-07-22 04:28:48
Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Position Trimmed by Cerity Partners LLC
Cerity Partners LLC decreased its position in Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) by 20.1% in the 1st quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 33,361 shares of the company’s stock after selling 8,376 shares during the quarter. Cerity Partners LLC’s holdings in […] - 2025-07-18 04:55:08
Ingrid Delaet Sells 457 Shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Stock
Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Get Free Report) insider Ingrid Delaet sold 457 shares of the business’s stock in a transaction on Thursday, July 10th. The stock was sold at an average price of $135.00, for a total transaction of $61,695.00. Following the completion of the transaction, the insider directly owned 4,730 shares in the […] - 2025-07-14 07:16:47
Bank of New York Mellon Corp Has $91.65 Million Stock Position in Neurocrine Biosciences, Inc. (NASDAQ:NBIX)
Bank of New York Mellon Corp lessened its holdings in Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) by 4.8% during the first quarter, HoldingsChannel reports. The fund owned 828,682 shares of the company’s stock after selling 41,608 shares during the quarter. Bank of New York Mellon Corp’s holdings in Neurocrine Biosciences were worth $91,652,000 as […] - 2025-07-11 05:40:57
Principal Financial Group Inc. Has $27.48 Million Stock Position in Neurocrine Biosciences, Inc. (NASDAQ:NBIX)
Principal Financial Group Inc. reduced its position in Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) by 1.6% in the 1st quarter, according to its most recent filing with the SEC. The firm owned 248,420 shares of the company’s stock after selling 4,049 shares during the period. Principal Financial Group Inc. owned 0.25% of Neurocrine Biosciences […] - 2025-07-09 05:51:40
Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Given Average Recommendation of “Moderate Buy” by Analysts
Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Get Free Report) has been assigned a consensus recommendation of “Moderate Buy” from the twenty-two brokerages that are presently covering the stock, Marketbeat Ratings reports. Three equities research analysts have rated the stock with a hold recommendation and nineteen have given a buy recommendation to the company. The average 12 […] - 2025-07-09 03:09:50
First Horizon Advisors Inc. Has $43,000 Stock Position in Neurocrine Biosciences, Inc. (NASDAQ:NBIX)
First Horizon Advisors Inc. decreased its position in shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) by 55.5% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 385 shares of the company’s stock after selling 480 shares during the quarter. First Horizon Advisors […] - 2025-07-08 05:49:06
Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Insider Jude Onyia Sells 20,362 Shares
Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Get Free Report) insider Jude Onyia sold 20,362 shares of the company’s stock in a transaction on Wednesday, July 2nd. The stock was sold at an average price of $130.13, for a total value of $2,649,707.06. Following the completion of the sale, the insider owned 18,289 shares of the company’s […] - 2025-07-08 05:06:50
Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Shares Sold by KBC Group NV
KBC Group NV lessened its position in Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) by 3.5% in the 1st quarter, Holdings Channel reports. The fund owned 13,835 shares of the company’s stock after selling 495 shares during the period. KBC Group NV’s holdings in Neurocrine Biosciences were worth $1,530,000 as of its most recent filing […] - 2025-07-04 06:58:45
New York State Teachers Retirement System Lowers Stock Holdings in Neurocrine Biosciences, Inc. (NASDAQ:NBIX)
New York State Teachers Retirement System lowered its stake in Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) by 1.9% during the 1st quarter, HoldingsChannel.com reports. The institutional investor owned 108,481 shares of the company’s stock after selling 2,055 shares during the quarter. New York State Teachers Retirement System’s holdings in Neurocrine Biosciences were worth $11,998,000 […] - 2025-07-04 06:14:58
Amalgamated Bank Has $5.28 Million Position in Neurocrine Biosciences, Inc. (NASDAQ:NBIX)
Amalgamated Bank lessened its holdings in Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) by 3.8% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 47,719 shares of the company’s stock after selling 1,895 shares during the quarter. Amalgamated Bank’s holdings in Neurocrine Biosciences were […] - 2025-07-03 06:14:49
Sumitomo Mitsui Trust Group Inc. Sells 1,399 Shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX)
Sumitomo Mitsui Trust Group Inc. reduced its holdings in shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) by 0.6% in the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 231,458 shares of the company’s stock after selling 1,399 shares during the quarter. Sumitomo Mitsui Trust […] - 2025-07-03 05:35:01
Golden State Wealth Management LLC Grows Position in Neurocrine Biosciences, Inc. (NASDAQ:NBIX)
Golden State Wealth Management LLC increased its position in Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) by 116.9% in the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 397 shares of the company’s stock after purchasing an additional 214 shares during the quarter. […] - 2025-07-02 05:01:01
Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Shares Acquired by Oppenheimer & Co. Inc.
Oppenheimer & Co. Inc. raised its holdings in shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) by 2.4% in the 1st quarter, HoldingsChannel.com reports. The fund owned 19,388 shares of the company’s stock after buying an additional 447 shares during the quarter. Oppenheimer & Co. Inc.’s holdings in Neurocrine Biosciences were worth $2,144,000 as […] - 2025-06-27 05:10:49
Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Shares Sold by Retirement Systems of Alabama
Retirement Systems of Alabama cut its holdings in shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) by 1.4% in the 1st quarter, Holdings Channel reports. The firm owned 121,352 shares of the company’s stock after selling 1,755 shares during the period. Retirement Systems of Alabama’s holdings in Neurocrine Biosciences were worth $13,422,000 at the […] - 2025-06-23 05:04:51
Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Shares Bought by QRG Capital Management Inc.
QRG Capital Management Inc. lifted its position in shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) by 7.1% in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 20,062 shares of the company’s stock after buying an additional 1,330 shares […] - 2025-06-20 06:54:59
Sowell Financial Services LLC Takes Position in Neurocrine Biosciences, Inc. (NASDAQ:NBIX)
Sowell Financial Services LLC bought a new stake in Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm bought 4,786 shares of the company’s stock, valued at approximately $529,000. Other institutional investors and hedge funds […] - 2025-06-20 05:29:06
Trust Point Inc. Sells 660 Shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX)
Trust Point Inc. decreased its holdings in shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) by 26.6% in the first quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 1,823 shares of the company’s stock after selling 660 shares during the period. Trust Point Inc.’s holdings in […] - 2025-06-19 05:35:02
XBI, EXAS, NBIX, NTRA: ETF Outflow Alert
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (Symbol: XBI) where we have detected an approximate $443.9 million dollar outflow -- that's a 8.8% decrease week over week - 2025-06-17 11:54:37
Merit Financial Group LLC Acquires 345 Shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX)
Merit Financial Group LLC raised its position in Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) by 9.1% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 4,153 shares of the company’s stock after purchasing an additional 345 shares during the quarter. Merit Financial Group […] - 2025-06-11 05:00:51

iShares Edge MSCI World Minimum Volatility UCITS ETF USD (Acc) NBIX holdings

DateNumber of NBIX Shares HeldBase Market Value of NBIX SharesLocal Market Value of NBIX SharesChange in NBIX Shares HeldChange in NBIX Base ValueCurrent Price per NBIX Share HeldPrevious Price per NBIX Share Held
2025-11-12 (Wednesday)22,009USD 3,232,022NBIX holding decreased by -9684USD 3,232,0220USD -9,684 USD 146.85 USD 147.29
2025-11-11 (Tuesday)22,009USD 3,241,706NBIX holding decreased by -60084USD 3,241,7060USD -60,084 USD 147.29 USD 150.02
2025-11-10 (Monday)22,009USD 3,301,790NBIX holding decreased by -51721USD 3,301,7900USD -51,721 USD 150.02 USD 152.37
2025-11-07 (Friday)22,009USD 3,353,511NBIX holding decreased by -53482USD 3,353,5110USD -53,482 USD 152.37 USD 154.8
2025-11-06 (Thursday)22,009USD 3,406,993NBIX holding increased by 23109USD 3,406,9930USD 23,109 USD 154.8 USD 153.75
2025-11-05 (Wednesday)22,009USD 3,383,884NBIX holding increased by 232415USD 3,383,8840USD 232,415 USD 153.75 USD 143.19
2025-11-04 (Tuesday)22,009NBIX holding decreased by -220USD 3,151,469NBIX holding decreased by -4160USD 3,151,469-220USD -4,160 USD 143.19 USD 141.96
2025-11-03 (Monday)22,229USD 3,155,629NBIX holding decreased by -27786USD 3,155,6290USD -27,786 USD 141.96 USD 143.21
2025-10-31 (Friday)22,229NBIX holding increased by 104USD 3,183,415NBIX holding increased by 129280USD 3,183,415104USD 129,280 USD 143.21 USD 138.04
2025-10-30 (Thursday)22,125USD 3,054,135NBIX holding increased by 442USD 3,054,1350USD 442 USD 138.04 USD 138.02
2025-10-29 (Wednesday)22,125USD 3,053,693NBIX holding decreased by -207090USD 3,053,6930USD -207,090 USD 138.02 USD 147.38
2025-10-28 (Tuesday)22,125NBIX holding decreased by -208USD 3,260,783NBIX holding decreased by -65494USD 3,260,783-208USD -65,494 USD 147.38 USD 148.94
2025-10-27 (Monday)22,333USD 3,326,277NBIX holding increased by 110325USD 3,326,2770USD 110,325 USD 148.94 USD 144
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of NBIX by Blackrock for IE00B8FHGS14

Show aggregate share trades of NBIX

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-11-04SELL-220143.870140.820 141.125USD -31,048 124.48 Loss of -3,661 on sale
2025-10-31BUY104143.470137.065 137.706USD 14,321 124.30
2025-10-28SELL-208147.380149.980 149.720USD -31,142 124.04 Loss of -5,341 on sale
2025-10-21SELL-208142.650142.970 142.938USD -29,731 123.51 Loss of -4,041 on sale
2025-10-14SELL-104137.230138.600 138.463USD -14,400 123.10 Loss of -1,598 on sale
2025-10-02SELL-414136.740137.630 137.541USD -56,942 122.95 Loss of -6,041 on sale
2025-09-25SELL-104140.890145.610 145.138USD -15,094 122.47 Loss of -2,358 on sale
2025-09-24SELL-456146.670148.000 147.867USD -67,427 122.33 Loss of -11,645 on sale
2025-09-16BUY95140.900141.020 141.008USD 13,396 121.97
2025-09-12SELL-412141.870144.040 143.823USD -59,255 121.75 Loss of -9,094 on sale
2025-07-23SELL-713133.660134.320 134.254USD -95,723 120.79 Loss of -9,600 on sale
2025-07-22SELL-928132.750133.320 133.263USD -123,668 120.71 Loss of -11,646 on sale
2025-07-21SELL-464131.830133.800 133.603USD -61,992 120.64 Loss of -6,014 on sale
2025-07-15SELL-928131.240136.250 135.749USD -125,975 120.32 Loss of -14,314 on sale
2025-07-11SELL-464133.460135.000 134.846USD -62,569 120.14 Loss of -6,824 on sale
2025-07-07BUY2,366127.880129.070 128.951USD 305,098 119.83
2025-07-02BUY223129.400130.420 130.318USD 29,061 119.64
2025-06-30SELL-675125.690127.360 127.193USD -85,855 119.59 Loss of -5,129 on sale
2025-06-27SELL-741125.420127.260 127.076USD -94,163 119.55 Loss of -5,575 on sale
2025-06-26BUY225126.710128.660 128.465USD 28,905 119.50
2025-06-25SELL-225127.780128.610 128.527USD -28,919 119.44 Loss of -2,044 on sale
2025-06-16SELL-2,302125.000126.000 125.900USD -289,822 119.18 Loss of -15,476 on sale
2025-06-13SELL-226124.390125.540 125.425USD -28,346 119.14 Loss of -1,421 on sale
2025-06-12SELL-450125.010125.910 125.820USD -56,619 119.09 Loss of -3,027 on sale
2025-06-11SELL-1,125124.170125.510 125.376USD -141,048 119.05 Loss of -7,111 on sale
2025-06-09SELL-225125.730126.890 126.774USD -28,524 118.96 Loss of -1,758 on sale
2025-05-30SELL-33,038123.020123.930 123.839USD -4,091,393 118.69 Loss of -170,187 on sale
2025-05-28SELL-323123.030124.300 124.173USD -40,108 118.61 Loss of -1,797 on sale
2025-05-21SELL-323120.560122.420 122.234USD -39,482 118.53 Loss of -1,197 on sale
2025-05-14SELL-4,290118.780121.850 121.543USD -521,419 118.41 Loss of -13,446 on sale
2025-05-09BUY1,670115.710119.670 119.274USD 199,188 118.43
2025-05-07SELL-1,288121.610122.570 122.474USD -157,747 118.41 Loss of -5,237 on sale
2025-05-01BUY322106.590109.550 109.254USD 35,180 118.69
2025-04-29SELL-3,531107.240108.590 108.455USD -382,955 118.91 Profit of 36,930 on sale
2025-04-28SELL-323106.460108.330 108.143USD -34,930 119.04 Profit of 3,520 on sale
2025-04-25BUY323106.730107.540 107.459USD 34,709 119.17
2025-04-23BUY1,050103.220106.200 105.902USD 111,197 119.47
2025-04-22BUY2,925101.740102.680 102.586USD 300,064 119.66
2025-04-15SELL-97296.16098.520 98.284USD -95,532 120.53 Profit of 21,625 on sale
2025-04-14BUY1,70894.89095.560 95.493USD 163,102 120.82
2025-04-11BUY1,64290.87091.280 91.239USD 149,814 121.15
2025-04-09SELL-96995.28095.560 95.532USD -92,571 121.80 Profit of 25,455 on sale
2025-04-08SELL-1,29287.54096.000 95.154USD -122,939 122.20 Profit of 34,942 on sale
2025-04-07SELL-32393.25096.440 96.121USD -31,047 122.54 Profit of 8,533 on sale
2025-04-04BUY32495.650100.520 100.033USD 32,411 122.86
2025-04-01BUY1,296107.000110.890 110.501USD 143,209 123.23
2025-03-31BUY2,914110.600112.600 112.400USD 327,534 123.39
2025-03-27SELL-632114.000115.800 115.620USD -73,072 123.63 Profit of 5,065 on sale
2025-03-21SELL-316111.920112.530 112.469USD -35,540 124.12 Profit of 3,682 on sale
2025-03-14BUY951110.750111.270 111.218USD 105,768 125.10
2025-03-13BUY317108.990110.210 110.088USD 34,898 125.33
2025-03-12BUY634109.070109.560 109.511USD 69,430 125.57
2025-03-11BUY634107.220110.070 109.785USD 69,604 125.84
2025-03-10SELL-316110.870113.870 113.570USD -35,888 126.07 Profit of 3,950 on sale
2025-03-07BUY5,355113.040115.000 114.804USD 614,775 126.27
2025-03-05BUY1,580113.850114.960 114.849USD 181,461 126.46
2025-03-04BUY632113.110114.390 114.262USD 72,214 126.68
2025-03-03BUY1,264114.480119.000 118.548USD 149,845 126.87
2025-02-27BUY316117.510117.850 117.816USD 37,230 127.16
2025-02-26BUY2,512117.590118.710 118.598USD 297,918 127.33
2025-02-25BUY628115.900120.000 119.590USD 75,103 127.52
2025-02-20BUY942116.110117.680 117.523USD 110,707 128.01
2025-02-05BUY314151.200153.090 152.901USD 48,011 129.28
2025-02-04BUY314152.420153.880 153.734USD 48,272 128.74
2025-01-31SELL-314151.820154.350 154.097USD -48,386 127.65 Loss of -8,303 on sale
2025-01-30BUY314153.290154.610 154.478USD 48,506 127.01
2025-01-29SELL-314150.680153.340 153.074USD -48,065 126.41 Loss of -8,374 on sale
2025-01-28BUY628150.710152.620 152.429USD 95,725 125.77
2025-01-27SELL-314148.190151.530 151.196USD -47,476 125.16 Loss of -8,175 on sale
2024-12-10SELL-317128.960130.480 130.328USD -41,314 123.00 Loss of -2,324 on sale
2024-12-03SELL-634125.440126.980 126.826USD -80,408 122.21 Loss of -2,923 on sale
2024-11-29SELL-316126.750127.080 127.047USD -40,147 121.90 Loss of -1,627 on sale
2024-11-22SELL-951125.650127.000 126.865USD -120,649 120.74 Loss of -5,825 on sale
2024-11-05SELL-2,528121.530122.000 121.953USD -308,297 118.16 Loss of -9,589 on sale
2024-10-29BUY316116.190116.860 116.793USD 36,907 116.04
2024-10-24BUY316115.520117.570 117.365USD 37,087 116.14
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of NBIX

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-19138,3040280,71449.3%
2025-09-18207,77644,506326,19463.7%
2025-09-17106,323343194,59754.6%
2025-09-1697,81119,146256,98038.1%
2025-09-1573,3630197,45737.2%
2025-09-1271,8171,305193,96837.0%
2025-09-1187,2040250,36934.8%
2025-09-10117,0990288,60540.6%
2025-09-09123,3791,879226,94154.4%
2025-09-08213,6691,667350,78760.9%
2025-09-05269,8828,988447,93060.3%
2025-09-04193,322481275,12970.3%
2025-09-03210,597108556,90537.8%
2025-09-02183,31915,512318,15057.6%
2025-08-29101,0617,590154,07965.6%
2025-08-28127,383487193,56165.8%
2025-08-27137,4541,818217,03363.3%
2025-08-26170,0223,558291,09658.4%
2025-08-25124,1533,639195,47663.5%
2025-08-22126,62910,885196,28864.5%
2025-08-21119,2451,265200,99059.3%
2025-08-20135,1384,637230,01058.8%
2025-08-19186,010535287,33064.7%
2025-08-18162,0387,351232,60969.7%
2025-08-15140,024100220,19963.6%
2025-08-14290,907253363,13980.1%
2025-08-13356,4048,730466,19176.5%
2025-08-12303,9754,067434,64169.9%
2025-08-11279,1915,617413,02767.6%
2025-08-08338,3850490,22069.0%
2025-08-07341,7192486,06070.3%
2025-08-06162,49452290,74155.9%
2025-08-05127,812122285,40144.8%
2025-08-04184,650798554,60133.3%
2025-08-01384,652274613,13762.7%
2025-07-31795,02721,403,51956.6%
2025-07-30277,359199566,94248.9%
2025-07-29235,4831,232479,50449.1%
2025-07-28128,7961,272304,76342.3%
2025-07-25164,9590533,68230.9%
2025-07-24143,137442360,99139.7%
2025-07-23127,087250336,56737.8%
2025-07-22110,378700199,61455.3%
2025-07-2194,76891171,48155.3%
2025-07-18136,185216238,83657.0%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.